CSI Market
Sign In | Register

Vsee Health Inc (VSEE) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access VSEE quarterly Cash Flow →
Looking at cash flow data from Vsee Health Inc through provides insight into Dec 31 2025's financial flexibility across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022)
Operating Activities
Income-14.71
Depreciation & amortization2.62
Amortization of Other Assets2.21
Increase (Decrease) in Deferred Revenue0.00
Goodwill, Impairment Loss56.68
Provision For Loan Losses Expensed1.03
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation8.03
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt-0.22
Interest Earned On Investments Held In Trust Accounts-
Change In Fair Value Of Pipe Forward Contract Derivative-
Financing Costs Included In Note-
Warrants Issued As Financing Cost In Note-
Investment Income Interest-
Gian Loss On Issuance Of Financial Instruments-
Fair Value Adjustment Of Financial Instruments-
Amortization Of Right Of Use Asset-
Increase Decrease In Operating Lease Liability-
Receivables Credit Loss Expense Reversal-
Gain On Forgiveness Of Debt-
Stock Issued For Conversion Of Underwriter Fee-
Stock Issued For Debt Settlement-
Shares Issued As Part Of Stock Grants To Vendors-
Loss On Issuance Of Financial Instrument-
Gain Loss On Issuance Of Financial Instruments-
Increase Decrease Change In Fair Value Of Financial Instruments-
Gain On Extinguishment Of E L O C-
Gain Loss On Termination Of Lease-
Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal-
Increase Decrease In Encompass Purchase Liability-
Income taxes0.05
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable1.61
Increase (Decrease) in Accounts Payable and Accrued Liabilities0.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.17
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-3.45
Investing Activities
Capital Expenditures-0.03
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Long-term Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Cash Acquired from Acquisition0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.03
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-0.15
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock1.50
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock-0.01
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Related Party As Advances-
Proceeds From M2b Note-
Repayment On Factoring Payable-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents0.12
Finance Lease Principal Payments-
Proceeds From Share Repurchase Liability-
Proceeds From Reverse Recapitalization-
Repayment On Extension Note-
Repayment On Additional Bridge Financing-
Repayment On Encompass Purchase Liability-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities8.42
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-3.48
Total Cash Flow4.94
4 historic quarters locked

Sign in to unlock the full Vsee Health Inc cash flow history.

Sign In Create Free Account

About Vsee Health Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001185185-26-001202

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License